These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14106543)

  • 21. THE SYNTHESIS OF ANTINEOPLASTIC AGENTS. XXXII. N-NITROSOUREAS. I.
    JOHNSTON TP; MCCALEB GS; MONTGOMERY JA
    J Med Chem; 1963 Nov; 6():669-81. PubMed ID: 14184923
    [No Abstract]   [Full Text] [Related]  

  • 22. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A; WAGNER M; RECHLER M; KOREN Z; BENJAMIN W
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 24. FLUORINATED PYRIMIDINES. XXI. THE TUMOR-INHIBITORY ACTIVITY OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
    HEIDELBERGER C; ANDERSON SW
    Cancer Res; 1964 Dec; 24():1979-85. PubMed ID: 14247510
    [No Abstract]   [Full Text] [Related]  

  • 25. EVALUATION OF ADDITIONAL CHEMOTHERAPEUTIC AGENTS EMPLOYING SARCOMA 180 IN MICE.
    FIELD JB; KLOETZEL MC; THIENES CH; MIRELES A; DOLENDO EC
    Cancer Res; 1964 Jan; 24():40-44. PubMed ID: 14106545
    [No Abstract]   [Full Text] [Related]  

  • 26. 4-(1-CARBOXYETHYL)-1,4-OXATHIANIUM BROMIDE.
    BAHNER CT; SENTER G
    J Med Chem; 1963 Nov; 6():820. PubMed ID: 14184965
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1961 Apr; 11():73-6. PubMed ID: 13780696
    [No Abstract]   [Full Text] [Related]  

  • 28. QUANTITATIVE CONCEPTS IN THE CLINICAL STUDY OF DRUGS.
    ZUBROD CG
    Adv Chemother; 1964; 12():9-34. PubMed ID: 14198208
    [No Abstract]   [Full Text] [Related]  

  • 29. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XV.
    LEITER J; ABBOTT BJ; BOURKE AR; SCHEPARTZ SA; WODINSKY I
    Cancer Res; 1963 Sep; 23():SUPPL1483-729. PubMed ID: 14070401
    [No Abstract]   [Full Text] [Related]  

  • 30. OSSAMYCIN, A NEW CYTOTOXIC AGENT.
    SCHMITZ H; JUBINSKI SD; HOOPER IR; CROOK KE; PRICE KE; LEIN J
    J Antibiot (Tokyo); 1965 Mar; 18():82-8. PubMed ID: 14326088
    [No Abstract]   [Full Text] [Related]  

  • 31. THE ANTILEUKEMIA ACTIVITY OF TYLOCREBRINE.
    GELLERT E; RUDZATS R
    J Med Chem; 1964 May; 7():361-2. PubMed ID: 14204981
    [No Abstract]   [Full Text] [Related]  

  • 32. "HYDROXYMETHYLGLYOXAL BIS(GUANYLHYDRAZONE)".
    DAVIDSON JD; ENGLE RR; MANCUSO RW
    Cancer Chemother Rep; 1963 Sep; 31():3-6. PubMed ID: 14066230
    [No Abstract]   [Full Text] [Related]  

  • 33. SYNTHESIS OF ISOTHIOCYANATES AS POTENTIAL ANTINEOPLASTIC AGENTS.
    BURCKHALTER JH; BARIANA DS
    J Med Chem; 1963 Mar; 6():203-5. PubMed ID: 14188797
    [No Abstract]   [Full Text] [Related]  

  • 34. THE INFLUENCE OF LEUROCRISTINE ON TRANSPLANATION IMMUNITY.
    RADZIKOWSKI C; GLYNN JP; GOLDIN A
    Cancer Chemother Rep; 1963 Oct; 32():15-8. PubMed ID: 14088829
    [No Abstract]   [Full Text] [Related]  

  • 35. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XVII.
    LEITER J; ABBOTT BJ; SCHEPARTZ SA; WODINSKY I
    Can Res Suppl; 1964 Feb; ():211-459. PubMed ID: 14119369
    [No Abstract]   [Full Text] [Related]  

  • 36. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XVI.
    LEITER J; ABBOTT BJ; BOURKE AR; SCHEPARTZ SA; WODINSKY I
    Can Res Suppl; 1963 Nov; ():1930-2033. PubMed ID: 14085011
    [No Abstract]   [Full Text] [Related]  

  • 37. SCREENING DATA FROM THE CANCER CHEMOTHERAPY NATIONAL SERVICE CENTER SCREENING LABORATORIES. XX.
    LEITER J; ABBOTT BJ; MACDONALD MM; SCHEPARTZ SA
    Cancer Res; 1964 Jul; 24():880-1080. PubMed ID: 14204395
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of treatment schedule on the chemotheapy of advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1960 Feb; 6():55-7. PubMed ID: 13841660
    [No Abstract]   [Full Text] [Related]  

  • 39. A SYSTEMATIC INVESTIGATION OF THIOXANTHEN-9-ONES AND ANALOGS AS POTENTIAL ANTITUMOR AGENTS.
    BLANZ EJ; FRENCH FA
    J Med Chem; 1963 Mar; 6():185-91. PubMed ID: 14188792
    [No Abstract]   [Full Text] [Related]  

  • 40. THE TREATMENT OF EXPERIMENTAL MOUSE HEMOBLASTOSIS. I. THE EFFECT OF SOME NEW FOLIC ACID ANTIMETABOLITES ON CELL TRANSPLANTED LEUKEMIA IN MICE OF THE AKR STRAIN.
    MOTYCKA K; SOUCEK J; SLAVIK K; JIRASEK J; JIRASEK A
    Neoplasma; 1964; 11():389-97. PubMed ID: 14200027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.